schizandrin b has been researched along with galactosamine in 2 studies
Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (galactosamine) | Trials (galactosamine) | Recent Studies (post-2010) (galactosamine) |
---|---|---|---|---|---|
321 | 1 | 218 | 3,542 | 7 | 704 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Du, X; Gao, Z; Li, L; Li, Q; Shen, L; Zhang, J; Zhao, Z; Zou, Y | 1 |
Hu, Y; Li, H; Li, R; Tian, Y; Wu, Z | 1 |
2 other study(ies) available for schizandrin b and galactosamine
Article | Year |
---|---|
Heat shock proteins 27 and 70 contribute to the protection of Schisandrin B against d-galactosamine-induced liver injury in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Cyclooctanes; Galactosamine; Gene Expression; HSP27 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Lignans; Liver; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Protective Agents; Quercetin; Schisandra | 2016 |
Protective effects of Schisandrin B against D-GalN-induced cell apoptosis in human hepatocyte (L02) cells via modulating Bcl-2 and Bax.
Topics: Apoptosis; bcl-2-Associated X Protein; Cell Line; Cyclooctanes; Galactosamine; Hepatocytes; Humans; Lignans; Polycyclic Compounds; Protective Agents; Proto-Oncogene Proteins c-bcl-2 | 2021 |